Ye Wang
5 Papers
Ye Wang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer.
TL;DR: It is indicated that T2a stage, pleura thickening/indentation might be prognostic factors in stage I NSCLC.
Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
Ye Wang,Yingqiu Song,Runze Wang,Yu Lian Wu,Mo Li,Ke Xu,Rong He,Zheng Wang,Qingqing Li,F. Kong,Tianlu Wang +10 more
TL;DR: The developed nomogram model of prediction demonstrated a good degree of accuracy and resilience in predicting the MPR following NCIO, indicating that it is a useful tool for assuring customized therapy for patients with possibly resectable LUSC.
1
In 18F-positron emission tomography/computed tomography-guided precision radiotherapy for centrally located non-small cell lung cancer, tumor related atelectasis is a prognostic factor of survival
Nianshuang Wang,Yun Qiao,Yingqiu Song,Zheng Wang,Xia Li,Ye Wang,Yusheng Wu,Rong He,Chenyu Wang,Yangwu Ren,Guang Li,Tianlu Wang +11 more
TL;DR: PET/CT can accurately stageNSCLC and better guide the treatment of NSCLC complicated with atelectasis and is a poor prognostic marker.
18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography-Guided Chest Radiotherapy Improves Survival in Patients with Extracranial Oligometastatic Non-small Cell Lung Cancer
Tian-Lu Wang,Yi-min Song,Zheng Zhou Wang,Lei He,Chenyu Wang,Yu Lian Wu,Ye Wang,Xiaofang Zhang,Guang-hu Li +8 more
- 03 Feb 2022
TL;DR: PET/CT-guided CRT is associated with improved clinical outcomes in patients with stage IV extracranial oligometastatic NSCLC and a more favorable prognosis in patients who underwent PET/CT evaluation.
Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis
Yinglin Song,Run Ze Wang,Zheng Wang,Rong He,Ke Xu,Chen-Yu Wang,Yu Lian Wu,Ye Wang,Xiaofang Zhang,Guang-hu Li,Tian-Lu Wang +10 more
TL;DR: PET/CT-guided TRT is associated with improved clinical outcomes in patients with stage IV extracranial oligometastatic NSCLC and a more favorable prognosis in patients who underwent PET/CT evaluation.